Precision Medicine: Applying Genomics Outside of Oncology

Get in Touch

Our Locations

Patrick Hurban, Ph.D.

Precision Medicine: Applying Genomics Outside of Oncology

Part two

Genomic technologies have been widely adopted within oncology, according to Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q²Solutions. In the second video from a three-part series, Hurban discusses the use of genomics for non-oncology trials and many other therapeutic areas as well. Watch to learn more.

Related Services & Solutions

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q² Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q² Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...